Sluggish Copaxone Rival And Delay To Generic Advair Hurt Mylan

 
• By David Wallace
  
Snail
Slower Than Expected Uptake For Glatiramer And A Delay To Wixela Inhub’s Approval Hit Mylan In 2018 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business